The mouse model in the study is reportedly quite different as it allows scientists to observe the aging process in a whole organism.

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

X-ray micro- and nano-tomography can provide clues on the processes that link the neurons in the gut and brain and may trigger Alzheimer’s.

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

Enduro officials say they are already working with global biotechnology companies to transform production and enable bioproduction at scale.

Cutting-edge editing techniques are accelerating efforts to create high-yield, resilient varieties of major agricultural products.

Researchers say study highlights the importance of rice breeding and cultivation measures in the mitigation of global warming.

A few companies are in clinicals with novel approaches to heal an initial brain injury or minimize secondary damage. Slow progress may be more related to investors’ misperceptions of the topic than ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

What especially shook investors was the prospect that China may have closed the tech gap with the United States in AI and especially DeepSeek’s claim that it developed R1 for just $5.6 million—a far ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.